Skip to main content

Finance

By HIMSS TV | 07:00 am | July 02, 2024
Dr. Yusuf Sherwani, CEO and cofounder of Pelago, describes how the company partners with employers and health plans to control the costs of substance misuse disorders and the effectiveness of the virtual evidence-based treatment platform.  
By HIMSS TV | 07:00 am | July 01, 2024
Rich Miller, chief innovation officer at QGenda, says that health systems need to address burnout, staffing and employee issues in a less fragmented way.  
By Adam Ang | 04:22 am | June 28, 2024
Also, insurtech company Huize from China is expanding to Southeast Asia.
By Jessica Hagen | 02:23 pm | June 25, 2024
The acquisition will see the publicly traded healthcare-navigation company become a privately held business.
By Jessica Hagen | 02:55 pm | June 24, 2024
The acquisition will allow the fertility and family-building company to provide its services in more than 100 countries and in over 225 languages.
By Jessica Hagen | 09:09 pm | June 21, 2024
Alfie's personalized treatment platform ObesityRx will be integrated into knownwell's primary care and metabolic health offerings.
By Jessica Hagen | 12:58 pm | June 20, 2024
Marigold Health secures $11 million for AI-enabled peer support platform for mental health and substance use disorders.
By HIMSS TV | 07:00 am | June 19, 2024
Aytan Dahukey, partner and private equity team leader, and healthcare team member at Sheppard Mullin, says that growth areas in private equity are opportunistic and discusses some challenges ahead.  
HIMSS24
By HIMSS TV | 06:09 pm | June 17, 2024
Dr. Harm Scherpbier, HealthShare Exchange CMIO, describes how the company's platform connects practices, payers and ACOs, allowing them to share patients’ data in real time across facilities to coordinate care seamlessly.  
By HIMSS TV | 04:53 pm | June 14, 2024
Aaron Gani, CEO and founder of RealizedCare, discusses the evolution of digital therapeutics, the FDA’s place in advancing them, keeping up with evolving technology, and the benefits of DTx modalities for the pharmaceutical industry.